RFG Advisory’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$729K Sell
1,874
-71
-4% -$27.6K 0.02% 512
2025
Q1
$846K Buy
1,945
+128
+7% +$55.7K 0.02% 441
2024
Q4
$670K Sell
1,817
-482
-21% -$178K 0.02% 446
2024
Q3
$1.2M Buy
2,299
+232
+11% +$121K 0.04% 339
2024
Q2
$1.12M Buy
2,067
+51
+3% +$27.6K 0.04% 326
2024
Q1
$1.05M Sell
2,016
-18
-0.9% -$9.33K 0.04% 345
2023
Q4
$959K Buy
2,034
+520
+34% +$245K 0.04% 331
2023
Q3
$659K Buy
1,514
+9
+0.6% +$3.92K 0.03% 356
2023
Q2
$669K Buy
1,505
+8
+0.5% +$3.55K 0.03% 372
2023
Q1
$688K Sell
1,497
-97
-6% -$44.6K 0.03% 344
2022
Q4
$761K Sell
1,594
-287
-15% -$137K 0.04% 320
2022
Q3
$998K Buy
1,881
+508
+37% +$270K 0.06% 259
2022
Q2
$653K Buy
1,373
+292
+27% +$139K 0.04% 299
2022
Q1
$531K Sell
1,081
-89
-8% -$43.7K 0.03% 308
2021
Q4
$542K Buy
1,170
+61
+6% +$28.3K 0.04% 287
2021
Q3
$413K Sell
1,109
-38
-3% -$14.2K 0.03% 305
2021
Q2
$438K Buy
1,147
+1
+0.1% +$382 0.04% 288
2021
Q1
$411K Sell
1,146
-41
-3% -$14.7K 0.04% 283
2020
Q4
$400K Hold
1,187
0.05% 274
2020
Q3
$319K Sell
1,187
-40
-3% -$10.8K 0.04% 297
2020
Q2
$323K Sell
1,227
-290
-19% -$76.3K 0.05% 277
2020
Q1
$344K Sell
1,517
-8
-0.5% -$1.81K 0.06% 236
2019
Q4
$460K Sell
1,525
-34
-2% -$10.3K 0.08% 205
2019
Q3
$374K Buy
1,559
+130
+9% +$31.2K 0.07% 205
2019
Q2
$403K Buy
1,429
+56
+4% +$15.8K 0.09% 184
2019
Q1
$395K Buy
+1,373
New +$395K 0.1% 168
2018
Q4
Sell
-801
Closed -$219K 272
2018
Q3
$219K Buy
+801
New +$219K 0.06% 270